CHARLES RIVER LABORATORIES INTERNATIONAL, INC.— Sankey Diagram
Quarterly mode · period ending 2025-12-27 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$994M
↓-0.8% -$8Mvs FY2024 (Q4)
Gross Profit
$994M
↓-0.8% -$8Mvs FY2024 (Q4)
Operating Income
$720M
↑+2.1% +$15Mvs FY2024 (Q4)
Net Income
$696M
↑+2.9% +$19Mvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $994M | $1.00B |
| COGS | $0 | $0 |
| Gross Profit | $994M | $1.00B |
| R&D | $0 | $0 |
| SG&A | $196M | $196M |
| D&A | $78M | $102M |
| Other OpEx | $42K | $0 |
| Operating Income | $720M | $705M |
| Interest Exp. | $24M | $28M |
| Other Non-Op | $0 | $0 |
| Pretax Income | $696M | $677M |
| Tax | $0 | $0 |
| Net Income | $696M | $677M |
QuarterCharts · SEC EDGAR data · CRL · Comparing FY2025 (Q4) vs FY2024 (Q4)